Analysis

WTO Vax Patent Deal Seen As Doing Little To Boost Access

By Ryan Davis (June 17, 2022, 10:13 PM EDT) -- The World Trade Organization's narrow agreement allowing developing countries to authorize the use of patents for COVID-19 vaccines has dismayed both supporters and opponents of waiving intellectual property rights amid the pandemic, and attorneys say its impact on vaccine access will be limited.

After nearly two years of negotiations, the WTO's 164 members reached a deal late Thursday that lets developing countries decide to permit unauthorized use of vaccine patents in some circumstances for five years. It bears little resemblance to the broad waiver for all countries of all forms of intellectual property for an array of pandemic-related technology, which India...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!